IP Library Granted Patent US 9,801,997
Granted Patent B2
US 9,801,997 · App. 14/819,929 · Granted Oct 31, 2017

Infusion pump systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,801,997
App. No.
14/819,929
Granted
Oct 31, 2017
Kind
B2
Abstract

Some embodiments of an infusion pump system can include a controller in which one or more features sets to be provided by the controller are enabled or disabled based upon the particular pump device that is connected to the controller. For example, in some embodiments, one or more advanced features of the controller are available to the user only when a first type of pump device (e.g., having predefined settings stored therein) is connected to the controller, and those advanced features of the controller are disabled when a second type of pump device is connected to the controller.

Claims (55)

1. A method of using a portable infusion pump system, the method comprising:

detecting, by a controller device, a communication connection with an insulin pump device that houses a drive system configured to dispense insulin, wherein the controller device is programmed transmit control signals over the communication connection to the insulin pump, the control signals controlling operation of the insulin pump to dispense insulin;

determining, by the controller device, that the insulin pump is in communication with the controller device over the communication connection;

receiving, at the controller device, one or more parameter settings transmitted by the insulin pump over the communication connection;

determining, by the controller device, whether to operate the insulin pump in a continuous monitoring mode of operation based on (i) the determination that the insulin pump is in communication with the controller device and (ii) the one or more parameter settings; and

automatically switching, in response to determining that the insulin pump is to be operated in the continuous monitoring mode of operation, from a first insulin delivery operating mode that does not include operating in a continuous monitoring mode to a second insulin delivery operating mode that includes operating in a continuous monitoring mode.

2. The method of claim 1 , wherein operating in the continuous monitoring mode comprises:

continuously monitoring glucose levels for a user of the portable infusion pump system; and

instructing, by the controller device, the insulin pump to dispense particular amounts of insulin determined based on the monitored glucose levels.

3. The method of claim 2 , wherein the continuously monitoring glucose levels comprises:

continuously receiving, at the controller device, information transmitted by a glucose sensor device that is configured to detect the user's glucose levels, wherein the information identifies the detected glucose levels for the user; and

processing, by the controller device, the glucose levels for the user received from the glucose sensor device.

4. The method of claim 3 , wherein the processing comprises displaying, by a display device that is part of the controller device, the glucose levels in a user interface.

5. The method of claim 3 , wherein the information is transmitted wirelessly by the glucose sensor device and received by a wireless communication device that is part of the controller device.

6. The method of claim 1 , wherein the controller device is contained within a housing that is physically separate from the insulin pump device.

7. The method of claim 1 , wherein the communication connection comprises an electrical connection between the controller device and the insulin pump device.

8. A method of using a portable infusion pump system, the method comprising:

detecting, by a controller device, a communication connection with an insulin pump device that houses a drive system configured to dispense insulin, wherein the controller device is programmed to transmit control signals over the communication connection to the insulin pump, the control signals controlling operation of the insulin pump to dispense insulin;

determining, by the controller device, that the insulin pump is in communication with the controller device over the communication connection;

receiving, at the controller device, one or more parameter settings transmitted by the insulin pump over the communication connection;

determining, by the controller device, whether to enable wireless communication by the controller device based on (i) the determination that the insulin pump is in communication with the controller device and (ii) the one or more parameter settings; and

automatically switching, in response to determining to enable wireless communication by the controller device, from a first insulin delivery operating mode in which wireless communication by the controller device is not enabled to a second insulin delivery operating mode in which wireless communication by the controller device is enabled.

9. The method of claim 8 , wherein the wireless communication is between, at least, a glucose sensor device and the controller device.

10. The method of claim 8 , wherein the wireless communication is between, at least, a blood glucose meter and the controller device.

11. The method of claim 8 , further comprising:

outputting, by the controller device, information indicating that wireless communication by the controller device has been enabled.

12. A portable infusion pump system comprising:

an insulin pump device comprising (i) a fluid cartridge containing insulin, (ii) a drive system configured to dispense the insulin, (iii) circuitry configured to store one or more parameter settings for the insulin pump device, and (iv) a communication interface configured to (a) transmit the one or more parameter settings for the insulin pump device and (b) receive control signals; and

a controller device comprising (i) a communication interface configured to (a) detect a communication connection with the insulin pump device, (b) receive information transmitted by the insulin pump device, including the one or more parameter settings, and (c) transmit the control signals over the communication connection to the insulin pump to control dispensation of insulin by the insulin pump, and (ii) control circuitry that is programmed to:

determine that the insulin pump is in communication with the controller device over the communication connection,

determine whether to operate the insulin pump in a continuous monitoring mode of operation based on (a) the determination that the insulin pump is in communication with the controller device and (b) the one or more parameter settings, and

automatically switch, in response to determining that the insulin pump is to be operated in the continuous monitoring mode of operation, from a first insulin delivery operating mode that does not include operating in a continuous monitoring mode to a second insulin delivery operating mode that includes operating in a continuous monitoring mode.

13. The system of claim 12 , wherein, under the continuous monitoring mode of operation, the control circuitry is further programmed to:

continuously monitor glucose levels for a user of the portable infusion pump system; and

direct the communication interface to transmit control signals to the insulin pump to dispense particular amounts of insulin determined based on the monitored glucose levels.

14. The system of claim 13 , further comprising:

a glucose sensor device configured to (i) detect the user's glucose levels and (ii) transmit information that identified the detected glucose levels;

wherein, under the continuous monitoring mode of operation:

the communication interface of the controller device is further configured to continuously receive the information transmitted by the glucose sensor device, and

the control circuitry of the controller device is further programmed to process the glucose levels for the user received from the glucose sensor device.

15. The system of claim 13 , wherein:

the controller device further comprises a display device, and

the processing comprises displaying the glucose levels in a user interface on the display device.

16. A portable infusion pump system comprising:

an insulin pump device comprising (i) a fluid cartridge containing insulin, (ii) a drive system configured to dispense the insulin, (iii) circuitry configured to store one or more parameter settings for the insulin pump device, and (iv) a communication interface configured to (a) transmit the one or more parameter settings for the insulin pump device and (b) receive control signals; and

a controller device comprising (i) a communication interface configured to (a) detect a communication connection with the insulin pump device, (b) receive information transmitted by the insulin pump device, including the one or more parameter settings, and (c) transmit the control signals over the communication connection to the insulin pump to control dispensation of insulin by the insulin pump, and (ii) control circuitry that is programmed to:

determine that the insulin pump is in communication with the controller device over the communication connection,

determine whether to enable wireless communication by the controller device based on (a) the determination that the insulin pump is in communication with the controller device and (b) the one or more parameter settings, and

automatically switch, in response to determining to enable wireless communication by the controller device, from a first insulin delivery operating mode in which wireless communication by the controller device is not enabled to a second insulin delivery operating mode in which wireless communication by the controller device is enabled.

17. The system of claim 16 , further comprising:

a glucose sensor device configured to (i) detect the user's glucose levels and (ii) transmit information that identified the detected glucose levels, wherein the glucose sensor device includes a wireless communication device configured to wirelessly transmit the information,

wherein the wireless communication is between, at least, the wireless communication device of the glucose sensor device and the communication interface of the controller device.

18. The system of claim 16 , further comprising:

a blood glucose meter configured to (i) analyze blood test strips and (ii) transmit glucose information detected from the blood glucose strips, wherein the blood glucose meter includes a wireless communication device configured to wirelessly transmit the glucose information,

wherein the wireless communication is between, at least, the wireless communication device of the blood glucose meter and the communication interface of the controller device.

Assignments (18)
SECURITY INTEREST Recorded Jan 10, 2025
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069870/0456 →
SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069870/0519 →
SECURITY INTEREST Recorded Sep 30, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069073/0912 →
SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069074/0001 →
SECURITY INTEREST Recorded Sep 24, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069030/0296 →
SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069030/0104 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
SECURITY AGREEMENT SUPPLEMENT Recorded Sep 7, 2023
From: INSULET CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 064840/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2023
From: BIGFOOT BIOMEDICAL, INC.
To: INSULET CORPORATION
Reel/Frame 063909/0826 →
RELEASE OF SECURITY INTEREST Recorded Feb 17, 2023
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 062793/0316 →
SECURITY INTEREST Recorded Feb 10, 2023
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 062702/0145 →
SECURITY INTEREST Recorded Mar 12, 2021
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 055583/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2016
From: ASANTE LLC
To: BIGFOOT BIOMEDICAL, INC
Reel/Frame 039683/0589 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2016
From: ASANTE SOLUTIONS, INC.
To: ASANTE LLC
Reel/Frame 039683/0481 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2016
From: ESTES, MARK C.; QI, WENKANG; HOPPER, PHILLIP
To: ASANTE SOLUTIONS, INC.
Reel/Frame 039435/0634 →